Drug Trial Radar · NCT05232279
Effect of Testofen on Erectile Function in an Adult Male Population
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
64
Actual
Start
Apr 19, 2022
Primary completion
Jul 22, 2026
Study completion Jul 22, 2026
Sponsor
- Lead sponsor
- RDC Clinical Pty LtdIndustry
- Sponsor type
- Industry
- Collaborators
- Pharmako Biotechnologies Pty Ltd; Gencor Pacific Limited, Hong Kong
- First posted
- Feb 9, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 40 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual function, and quality of life.
Conditions
- Erectile Dysfunction
Interventions
Testofen 300mgDrug
Testofen in capsule form - To be taken as a 300mg dosage (2 capsules) once daily for 12 weeks.
Testofen 600mgDrug
Testofen in capsule form - To be taken as a 600mg dosage (2 capsules) once daily for 12 weeks.
Placebo comparatorDrug
The placebo will consist of maltodextrin and will appear identical to the Testofen capsules. The placebo will be administered as per the active treatment - 2 capsules once daily for 12 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in International Index of Erectile Function (IIEF) questionnaireTime frame: Baseline prior to commencement of study product, Week 4, Week 8 and Week 12
- Change in Erection Hardness Score (EHS)Time frame: Baseline prior to commencement of study product, Week 4, Week 8 and Week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
RDC Clinical Pty Ltd
Brisbane, Queensland, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.